Incomplete antibody evolution and seroreversion after treatment of primary HIV type 1 infection: what is the clinical significance?

Clin Infect Dis. 2005 Mar 15;40(6):874-5. doi: 10.1086/428131. Epub 2005 Feb 18.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Administration Schedule
  • HIV Antibodies / blood*
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • Humans

Substances

  • Anti-HIV Agents
  • HIV Antibodies